<table id="table14" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 14: Drug Interactions: Pharmacokinetic Parameters for Darunavir in the Presence of Co-administered Drugs</caption>
<col align="left" valign="bottom" width="15%"></col>
<col align="center" valign="bottom" width="15%"></col>
<col align="center" valign="bottom" width="15%"></col>
<col align="center" valign="bottom" width="5%"></col>
<col align="center" valign="bottom" width="5%"></col>
<col align="center" valign="bottom" width="15%"></col>
<col align="center" valign="bottom" width="15%"></col>
<col align="center" valign="bottom" width="15%"></col>
<thead>
<tr stylecode="Botrule">
<th rowspan="2" stylecode="Lrule Rrule">Co-Administered Drug</th>
<th colspan="2" stylecode="Rrule">Dose/Schedule</th>
<th rowspan="2" stylecode="Rrule">N</th>
<th rowspan="2" stylecode="Rrule">PK</th>
<th colspan="3" stylecode="Rrule">LS Mean Ratio (90% CI) of <content stylecode="underline">Darunavir</content> Pharmacokinetic Parameters With/Without Co-administered Drug<br/> No Effect =1.00</th>
</tr>
<tr>
<th align="center" stylecode="Rrule">Co-Administered Drug</th>
<th stylecode="Rrule">Darunavir/ritonavir</th>
<th stylecode="Rrule">C<sub>max</sub>
</th>
<th stylecode="Rrule">AUC</th>
<th stylecode="Rrule">C<sub>min</sub>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="8" valign="top">N = number of subjects with data</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td colspan="8" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With Other HIV Protease Inhibitors</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atazanavir</td>
<td stylecode="Rrule">300 mg q.d.<footnote>q.d. = once daily</footnote>
</td>
<td stylecode="Rrule">400/100 mg b.i.d. <footnote>b.i.d. = twice daily</footnote>
</td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.02<br/>(0.96–1.09)</td>
<td stylecode="Rrule">1.03<br/>(0.94–1.12)</td>
<td stylecode="Rrule">1.01<br/>(0.88–1.16)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Indinavir</td>
<td stylecode="Rrule">800 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">9</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.11<br/>(0.98–1.26)</td>
<td stylecode="Rrule">1.24<br/>(1.09–1.42)</td>
<td stylecode="Rrule">1.44<br/>(1.13–1.82)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule"></td>
<td stylecode="Rrule" valign="top">400/100 mg b.i.d.</td>
<td stylecode="Rrule">1200/100 mg b.i.d.<footnote id="t12ft3">The pharmacokinetic parameters of darunavir in this study were compared with the pharmacokinetic parameters following administration of darunavir/ritonavir 600/100 mg b.i.d.</footnote>
</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.79<br/>(0.67–0.92)</td>
<td stylecode="Rrule">0.62<br/>(0.53–0.73)</td>
<td stylecode="Rrule">0.49<br/>(0.39–0.63)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lopinavir/ Ritonavir</td>
<td stylecode="Rrule" valign="top">533/133.3 mg b.i.d.</td>
<td stylecode="Rrule">1200 mg b.i.d.<footnoteref idref="t12ft3"></footnoteref>
</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.79<br/>(0.64–0.97)</td>
<td stylecode="Rrule">0.59<br/>(0.50–0.70)</td>
<td stylecode="Rrule">0.45<br/>(0.38–0.52)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Saquinavir hard gel capsule<br/>
</td>
<td stylecode="Rrule">1000 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.83<br/>(0.75–0.92)</td>
<td stylecode="Rrule">0.74<br/>(0.63–0.86)</td>
<td stylecode="Rrule">0.58<br/>(0.47–0.72)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="8" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With Other  HIV Antiretrovirals</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Didanosine</td>
<td stylecode="Rrule">400 mg q.d.</td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.93<br/>(0.86–1.00)</td>
<td stylecode="Rrule">1.01<br/>(0.95–1.07)</td>
<td stylecode="Rrule">1.07<br/>(0.95–1.21)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Efavirenz</td>
<td stylecode="Rrule">600 mg q.d.</td>
<td stylecode="Rrule">300/100 mg b.i.d.</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.85<br/>(0.72–1.00)</td>
<td stylecode="Rrule">0.87<br/>(0.75–1.01)</td>
<td stylecode="Rrule">0.69<br/>(0.54–0.87)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Etravirine</td>
<td stylecode="Rrule">200 mg b.i.d.</td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.11<br/>(1.01–1.22)</td>
<td stylecode="Rrule">1.15<br/>(1.05–1.26)</td>
<td stylecode="Rrule">1.02<br/>(0.90–1.17)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Nevirapine</td>
<td stylecode="Rrule">200 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">8</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.40 <footnote id="t12ft4">Ratio based on between-study comparison.</footnote>
<br/>(1.14–1.73)</td>
<td stylecode="Rrule">1.24 <footnoteref idref="t12ft4"></footnoteref>
<br/>(0.97–1.57)</td>
<td stylecode="Rrule">1.02 <footnoteref idref="t12ft4"></footnoteref>
<br/>(0.79–1.32)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rilpivirine</td>
<td stylecode="Rrule">150 mg q.d.</td>
<td stylecode="Rrule">800/100 mg q.d.</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.90 <br/>(0.81–1.00)</td>
<td stylecode="Rrule">0.89 <br/>(0.81–0.99)</td>
<td stylecode="Rrule">0.89 <br/>(0.68–1.16)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Tenofovir Disoproxil Fumarate</td>
<td stylecode="Rrule">300 mg q.d.</td>
<td stylecode="Rrule">300/100 mg b.i.d.</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.16<br/>(0.94–1.42)</td>
<td stylecode="Rrule">1.21<br/>(0.95–1.54)</td>
<td stylecode="Rrule">1.24<br/>(0.90–1.69)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="8" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With HCV NS3-4A Protease Inhibitors</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Boceprevir<footnote>AUC is AUC<sub>(0–last)</sub>; N=10 for C<sub>min</sub> in the reference arm</footnote>
</td>
<td stylecode="Rrule">800 mg three times daily</td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.64<br/>(0.58–0.71)</td>
<td stylecode="Rrule">0.56<br/>(0.51–0.61)</td>
<td stylecode="Rrule">0.41<br/>(0.38–0.45)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Telaprevir</td>
<td stylecode="Rrule">750 mg every 8 hours<br/>
<br/>1125 mg every 12 hours</td>
<td stylecode="Rrule">600/100 mg b.i.d.<br/>
<br/>
<br/>600/100 mg b.i.d.</td>
<td stylecode="Rrule">11<footnote>N=14 for C<sub>max</sub>
</footnote>
<br/>
<br/>
<br/>15</td>
<td stylecode="Rrule">↓ <br/>
<br/>
<br/>↓</td>
<td stylecode="Rrule">0.60 <br/>(0.56–0.64) <br/>
<br/>0.53 <br/>(0.47–0.59)</td>
<td stylecode="Rrule">0.60 <br/>(0.57–0.63) <br/>
<br/>0.49 <br/>(0.43–0.55)</td>
<td stylecode="Rrule">0.58 <br/>(0.52–0.64) <br/>
<br/>0.42 <br/>(0.35–0.51)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Simeprevir</td>
<td stylecode="Rrule" valign="top">50 mg q.d. <footnote>The dose of simeprevir in this interaction study was 50 mg when co-administered in combination with darunavir/ritonavir compared to 150 mg once daily in the simeprevir alone treatment group<sup>.</sup>
</footnote>
</td>
<td stylecode="Rrule" valign="top">800 mg q.d.</td>
<td stylecode="Rrule" valign="top">25<footnote>Maximum number of subjects</footnote>
</td>
<td stylecode="Rrule" valign="top">↑</td>
<td stylecode="Rrule" valign="top">1.04<br/>(0.99–1.10)</td>
<td stylecode="Rrule" valign="top">1.18<br/>(1.11–1.25)</td>
<td stylecode="Rrule" valign="top">1.31<br/> (1.13–1.52)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="8" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With Other Drugs</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Artemether/ Lumefantrine</td>
<td stylecode="Rrule">80/480 mg (6 doses at 0, 8, 24, 36, 48, and 60 hours) </td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.00<br/>(0.93–1.07)</td>
<td stylecode="Rrule">0.96<br/>(0.90–1.03)</td>
<td stylecode="Rrule">0.87<br/>(0.77–0.98)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Carbamazepine</td>
<td stylecode="Rrule">200 mg b.i.d.</td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.04<br/>(0.93–1.16)</td>
<td stylecode="Rrule">0.99<br/>(0.90–1.08)</td>
<td stylecode="Rrule">0.85<br/>(0.73–1.00)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Clarithromycin</td>
<td stylecode="Rrule">500 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.83<br/>(0.72–0.96)</td>
<td stylecode="Rrule">0.87<br/>(0.75–1.01)</td>
<td stylecode="Rrule">1.01<br/>(0.81–1.26)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ketoconazole</td>
<td stylecode="Rrule">200 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.21<br/>(1.04–1.40)</td>
<td stylecode="Rrule">1.42<br/>(1.23–1.65)</td>
<td stylecode="Rrule">1.73<br/>(1.39–2.14)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Omeprazole</td>
<td stylecode="Rrule">20 mg q.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.02<br/>(0.95–1.09)</td>
<td stylecode="Rrule">1.04<br/>(0.96–1.13)</td>
<td stylecode="Rrule">1.08<br/>(0.93–1.25)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Paroxetine</td>
<td stylecode="Rrule">20 mg q.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.97<br/>(0.92–1.02)</td>
<td stylecode="Rrule">1.02<br/>(0.95–1.10)</td>
<td stylecode="Rrule">1.07<br/>(0.96–1.19)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Pitavastatin</td>
<td stylecode="Rrule" valign="top">4 mg q.d.</td>
<td stylecode="Rrule" valign="top">800/100 mg q.d.</td>
<td stylecode="Rrule" valign="top">27</td>
<td stylecode="Rrule" valign="top">↔</td>
<td stylecode="Rrule" valign="top">1.06<br/>(1.00–1.12)</td>
<td stylecode="Rrule" valign="top">1.03<br/>(0.95–1.12)</td>
<td stylecode="Rrule" valign="top">NA</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ranitidine</td>
<td stylecode="Rrule">150 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.96<br/>(0.89–1.05)</td>
<td stylecode="Rrule">0.95<br/>(0.90–1.01)</td>
<td stylecode="Rrule">0.94<br/>(0.90–0.99)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top">Rifabutin</td>
<td stylecode="Rrule" valign="top">150 mg q.o.d.<footnote>q.o.d. = every other day</footnote>
</td>
<td stylecode="Rrule" valign="top">600/100 mg b.i.d.</td>
<td stylecode="Rrule" valign="top">11</td>
<td stylecode="Rrule" valign="top">↑</td>
<td stylecode="Rrule" valign="top">1.42<br/>(1.21–1.67)</td>
<td stylecode="Rrule" valign="top">1.57<br/>(1.28–1.93)</td>
<td stylecode="Rrule" valign="top">1.75<br/>(1.28–2.37)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Sertraline</td>
<td stylecode="Rrule">50 mg q.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.01<br/>(0.89–1.14)</td>
<td stylecode="Rrule">0.98<br/>(0.84–1.14)</td>
<td stylecode="Rrule">0.94<br/>(0.76–1.16)</td>
</tr>
</tbody>
</table>